| Authors: |
Avau B; Centre for Evidence-Based Practice (CEBaP), Belgian Red Cross, Motstraat 42, 2800, Mechelen, Belgium. bert.avau@cebap.org., Van Remoortel H; Centre for Evidence-Based Practice (CEBaP), Belgian Red Cross, Motstraat 42, 2800, Mechelen, Belgium., Laermans J; Centre for Evidence-Based Practice (CEBaP), Belgian Red Cross, Motstraat 42, 2800, Mechelen, Belgium., Bekkering G; Center for Evidence-Based Medicine, Leuven, Belgium.; Cochrane Belgium, Leuven, Belgium., Fergusson D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.; Department of Medicine, University of Ottawa, Ottawa, Canada.; Canadian Blood Services, Ottawa, Canada., Georgsen J; South Danish Transfusion Service, Odense University Hospital, Odense, Denmark., Manzini PM; SC Banca del Sangue Servizio di Immunoematologia, University Hospital Città della Salute e della Scienza di Torino, Torino, Italy., Ozier Y; University Hospital of Brest, Brest, France., De Buck E; Centre for Evidence-Based Practice (CEBaP), Belgian Red Cross, Motstraat 42, 2800, Mechelen, Belgium.; Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium., Compernolle V; Blood Services, Belgian Red Cross, Mechelen, Belgium.; Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Vandekerckhove P; Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium.; Belgian Red Cross, Mechelen, Belgium. |
